** Bruker Corp's BRKR.O shares down 10.4% premarket to
$65, lowest since early Dec, after life sciences diagnostics
equipment provider raises equity
** Co late Weds announced pricing of 6 mln share offering
with BofA and JP Morgan as jt bookrunners
** Offering priced at $68, 6.3% discount to stock's last
close, IFR reports, which equates to $408 mln gross raise
** Co plans to use net proceeds to pay down debt following
recent acquisitions, including to partially repay borrowings
under revolving credit agreement
** Bruker on Apr 30 completed all-cash ~$923 mln purchase of
molecular diagnostics firm ELITechGroup and on May 6 closed
all-cash ~$393 mln acquisition of life sciences tool maker
NanoString Technologies
** With ~145.3 mln shares outstanding, Bruker has $10.5 bln
market cap
** Through Weds, BRKR shares off ~1% YTD and off >20% from
record highs hit in mid-Mar
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-646-279-6380))